MSL
VCYT icon

Mackay Shields LLC’s Veracyte VCYT Stock Holding History

Mackay Shields LLC’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-26,600
Closed -$1.43M – 1311
2021
Q1 		$1.43M Sell
26,600
-15,200
-36% -$875K 0.01% 896
2020
Q4 		$2.04M Buy
+41,800
New +$1.94M 0.01% 846
2020
Q2 		– Sell
-16,900
Closed -$410K – 1591
2020
Q1 		$410K Buy
+16,900
New +$425K ﹤0.01% 1172

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackay Shields LLC's VCYT Position: Q2 2021 in Review

Mackay Shields LLC sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 26,600 shares — an estimated $1.43M sold.

Mackay Shields LLC first reported a position in VCYT in Q1 2020 and held it in 3 quarters. The position peaked at $2.04M in Q4 2020. 214 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.

  • Mackay Shields LLC reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 26,600 Veracyte shares in Q2 2021, an estimated $1.43M.
  • Mackay Shields LLC first reported a position in Veracyte in Q1 2020 and held it in 3 quarters.
  • Mackay Shields LLC's Veracyte position peaked at $2.04M in Q4 2020.
  • 214 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.